The Projects of this SPORE will use human prostate cancer specimens for translational research directed at improving the prevention, detection, and therapy of prostate cancer. The Tissue Resource and Pathology Core will provide investigators at The University of Texas M.D. Anderson Cancer Center (MDACC) and other collaborating institutions with high-quality tissue and serum samples from patients with prostate cancer treated at MDACC. Tumor cell lines and xenografts from patients' tumor samples will also be maintained in the in the Core and distributed to investigators as required. This SPORE facility will subsume the existing MDACC Prostate Cancer Tissue Bank and provide for special needs not covered by existing MDACC facilities maintained by the NCI Cancer Center Support Grant. Standardized and centralized procedures for procurement, processing, storage, quality control, histopathological evaluation, and distribution of samples will ensure optimal utilization and distribution of limited tissue samples according to the guidelines established by the Tissue Acquisition and Distribution Committee. A computerized Core database containing records of all samples, both stored and distributed, and their histopathological evaluation, and distribution of samples will ensure optimal utilization and distribution of limited tissue samples according to the guidelines established by the Tissue Acquisition and Distribution Committee. A computerized Core database containing records of all samples, both stored and distributed, and their histopathological characteristics will ensure efficient correlation with the clinical database and with the SPORE project results, facilitate adjustments in response to the tissue requirements of the investigators of MDACC and collaborating institutions, and provide information on sample availability for future distribution through the NCI-sponsored tissue network. The participation of pathologists with expertise in prostate cancer in all aspects of the operation, including histopathological evaluation and quality-control procedure will ensure maximal utilization of samples without compromising patient care. This centralized comprehensive Core will ensure the success of the multi-disciplinary and translational research projects outlined in this proposal.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
1P50CA090270-01
Application #
6466092
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2001-06-01
Project End
2006-12-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Salameh, Ahmad; Lee, Alessandro K; Cardó-Vila, Marina et al. (2015) PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3. Proc Natl Acad Sci U S A 112:8403-8
Pasqualini, Renata; Millikan, Randall E; Christianson, Dawn R et al. (2015) Targeting the interleukin-11 receptor ? in metastatic prostate cancer: A first-in-man study. Cancer 121:2411-21
Euscher, Elizabeth; Fox, Patricia; Bassett, Roland et al. (2013) The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma. Am J Surg Pathol 37:1728-36
Efstathiou, Eleni; Karlou, Maria; Wen, Sijin et al. (2013) Integrated Hedgehog signaling is induced following castration in human and murine prostate cancers. Prostate 73:153-61
Hosain, G M Monawar; Sanderson, Maureen; Du, Xianglin L et al. (2012) Racial/ethnic differences in treatment discussed, preferred, and received for prostate cancer in a tri-ethnic population. Am J Mens Health 6:249-57
Heymach, John V; Shackleford, Terry J; Tran, Hai T et al. (2011) Effect of low-fat diets on plasma levels of NF-?B-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer. Cancer Prev Res (Phila) 4:1590-8
Hosain, G M Monawar; Sanderson, Maureen; Du, Xianglin L et al. (2011) Racial/ethnic differences in predictors of PSA screening in a tri-ethnic population. Cent Eur J Public Health 19:30-4
Kadowaki, Yoshihiko; Chari, Nikhil S; Teo, Albert E K et al. (2011) PI3 Kinase inhibition on TRAIL-induced apoptosis correlates with androgen-sensitivity and p21 expression in prostate cancer cells. Apoptosis 16:627-35
Efstathiou, Eleni; Abrahams, Neil A; Tibbs, Rita F et al. (2010) Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic classification. Eur Urol 57:1030-8
Ravoori, Murali; Czaplinska, Aneta J; Sikes, Charles et al. (2010) Quantification of mineralized bone response to prostate cancer by noninvasive in vivo microCT and non-destructive ex vivo microCT and DXA in a mouse model. PLoS One 5:e9854

Showing the most recent 10 out of 153 publications